Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Apeiron Capital Investment Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive ...
Docs: "Apeiron Capital Investment Corp. Announces Termination of Business Combination Agreement and Liquidation BOSTON, MA – August 11, 2023 - Apeiron Capital Investment Corp. announced today that it has notified GIO World Health, Ltd. that the Company has elected to terminate the Business Combination Agreement between the parties, dated as of March 8, 2023 , pursuant to Section 8.1 thereof, effective as of August 14, 2023 . Upon the effectiveness of the Termination, the Business Combination Agreement will be of no further force and effect, with the exception of the specified provisions in Section 8.2 of the Business Combination Agreement, which shall survive the termination of the Business Combination Agreement and remain in full force and effect in accordance with their respective terms. Due to..."
05/10/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amendment No. 1 to Business Combination Agreement, by and among Apeiron Capital Investment Corp., Apeiron Capital Sponsor, LLC, GIO World Health Limited, Deven Patel, and the Sellers party thereto",
"PROMISSORY NOTE Dated as of April 5, 2023 Principal Amount: $250,000.00 New York, New York Apeiron Capital Investment Corp., a special purpose acquisition company incorporated as a Delaware corporation , promises to pay to the order of SIA Ventures, LLC or its registered assigns or successors in interest , the principal sum of $250,000.00 in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note. 1. Principal. The principal balance of this Note shall be due and payable by the Maker , subject to S..."
03/14/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "BUSINESS COMBINATION AGREEMENT by and among APEIRON CAPITAL INVESTMENT CORP., as the Purchaser, APEIRON CAPITAL SPONSOR, LLC, in the capacity as the Purchaser Representative, GIO WORLD HEALTH, LIMITED, as the Company, THE SHAREHOLDERS OF THE COMPANY NAMED HEREIN, as the Sellers, and DEVEN PATEL , in the capacity as the Seller Representative, Dated as of March 8, 2023",
"FORM OF VOTING AGREEMENT",
"FORM OF LOCK-UP AGREEMENT",
"NON-COMPETITION AND NON-SOLICITATION AGREEMENT",
"SELLER REGISTRATION RIGHTS AGREEMENT"
03/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "GIO World Health Ltd, a Leading Stem Cell Life Science Company, Announces Plans to Go Public via Business Combination with Apeiron Capital Investment Corp. · GIO World Health Ltd has entered into a business combination agreement with Apeiron Capital Investment Corp . · The post-closing combined public company, which will be named GIO World Health Holdings, Inc., values GIO World Health in the proposed transaction at a pre-money enterprise value of $250 million. · Current GIO World Health shareholders will retain 100% of their equity in the post-closing combined public company and will continue to own approximately 80.83% of the post-closing combined public company on a pro forma basis, assuming no redemptions by Apeiron Capital’ s public shareholders, and that all GIO ..."
02/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
12/16/2022 8-K Other Events  Interactive Data
11/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/29/2021 8-K Quarterly results
11/18/2021 8-K Other Events, Financial Statements and Exhibits
Docs: "Audited Balance Sheet as of November 12, 2021"
11/12/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "Underwriting Agreement, by and among the Company and Cantor Fitzgerald & Co",
"Amended and Restated Certificate of Incorporation",
"Warrant Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent",
"Letter Agreement, by and among the Company, its officers, its directors and the Sponsor",
"Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration and Shareholder Rights Agreement, by and between the Company and certain security holders",
"Administrative Support Agreement, by and between the Company and the Sponsor",
"Private Placement Warrants Purchase Agreement, by and between the Company and the Sponsor",
"Private Placement Warrants Purchase Agreement, by and between the Company and Cantor Fitzgerald & Co.",
"Press Release"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy